Financing, Equity Capital Markets

Menlo Therapeutics Inc.

01/18
|
$136.9 Million
Piper Sandler served as bookrunner for Menlo Therapeutics Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma